Targeting TTK Inhibits Tumorigenesis of T‐Cell Lymphoma Through Dephosphorylating p38α and Activating AMPK/mTOR Pathway

Targeting TTK Inhibits Tumorigenesis of T‐Cell Lymphoma Through Dephosphorylating p38α and Activating AMPK/mTOR Pathway

Abstract T‐cell lymphoma (TCL) is a group of non‐Hodgkin's lymphoma with high heterogeneity and unfavorable prognosis. Current standard treatments have demonstrated limited efficacy in improving the outcomes for TCL patients. Therefore, identification of novel drug targets is urgently needed to...

Full description

Bibliographic Details
Main Authors: Bingyu Liu, Tiange Lu, Mengfei Ding, Xiaoli Zhou, Yujie Jiang, Juanjuan Shang, Wenyue Sun, Shunfeng Hu, Xin Wang, Xiangxiang Zhou
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:Advanced Science
Subjects:
p38α
phosphorylation
T‐cell lymphoma
threonine tyrosine kinase
ubiquitination
Online Access:https://doi.org/10.1002/advs.202413990

Internet

https://doi.org/10.1002/advs.202413990

Similar Items